Finance

Lists
4569:TYO
Kyorin Pharmaceutical Co Ltd
Â¥1,128.00
-1.57%
(-18.00) 1D
Sep 18, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4569...
Open
Â¥1,146
High
Â¥1,149
Low
Â¥1,128
Mkt. cap
67.62B
Avg. vol.
270.68K
Volume
204.10K
Dividend
5.05%
Quarterly dividend
Â¥14
Ex-dividend date
Sep 29, 2026
P/E ratio
29.83
52-wk high
Â¥1,725
52-wk low
Â¥1,052
EPS
Â¥38
Shares outstanding
63.52M
No. of employees
2K
Open
Â¥1,146
High
Â¥1,149
Low
Â¥1,128
Mkt. cap
67.62B
Avg. vol.
270.68K
Volume
204.10K
Dividend
5.05%
Quarterly dividend
Â¥14
Ex-dividend date
Sep 29, 2026
P/E ratio
29.83
52-wk high
Â¥1,725
52-wk low
Â¥1,052
EPS
Â¥38
Shares outstanding
63.52M
No. of employees
2K
About Kyorin Pharmaceutical Co Ltd
CEO-
Employees1.98K
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitekyorin-pharm.co.jp
Last report
Jul 30, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
29.65B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
28.50B
33.72B
33.80B
29.65B
Cost of goods sold
16.87B
19.09B
21.71B
17.48B
Cost of revenue
16.87B
19.09B
21.71B
17.48B
Research and development expenses
-
-
12.06B
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
12.64B
11.39B
1.07B
11.21B
Operating expense
12.69B
11.39B
13.13B
11.22B
Total operating expenses
29.56B
30.48B
34.84B
28.69B
Operating income
-1.06B
3.24B
-1.04B
964.00M
Other non operating income
11.00M
12.00M
13.00M
15.00M
EBT including unusual items
-699.00M
3.49B
-1.07B
1.19B
EBT excluding unusual items
-1.04B
3.51B
-1.07B
1.24B
Income tax expense
-93.00M
869.00M
-402.00M
363.00M
Effective tax rate
13.30%
24.87%
37.47%
30.58%
Other operating expenses
-
-
-
-
Net income
-606.00M
2.62B
-671.00M
824.00M
Net profit margin
-2.13%
7.78%
-1.99%
2.78%
Earnings per share
-
-
-
-
Interest and investment income
38.00M
235.00M
12.00M
288.00M
Interest expense
-61.00M
-59.00M
-70.00M
-59.00M
Net interest expenses
-23.00M
176.00M
-58.00M
229.00M
Depreciation and amortization charges
3.00M
3.00M
2.00M
2.00M
EBITDA
82.00M
4.39B
121.75M
2.13B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps